Anteris Beats on Loss Per Share but Revenue Comes In Far Below Expectations
AVR sits 79% above its 52-week low of $3.3.
Summary
Anteris posted a Q3 adjusted loss of 28 cents a share, better than the 31-cent consensus, but revenue of $519 thousand badly missed the $2.90 million analysts expected. The company lost $26.83 million in the quarter and reported $22.9M in Q3 cash outflows. This lands alongside the 10-Q filed this evening, which disclosed a $78.5M nine-month net loss, $236.3M in cash, and material weaknesses in internal control that remain unremediated. The stock is down 23.6% this quarter, and the revenue shortfall undercuts the buy-rated consensus and $15 median price target. Cash burn against the $250M ATM shelf is the number that matters from here.
At the time of this announcement, AVR was trading at $5.90 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $574.2M. The 52-week trading range was $3.30 to $11.06. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.